• CBD Attenuates Orofacial Pain via Endocannabinoid and Seroto

  2026-05-15

  This study demonstrates that cannabidiol (CBD) alleviates both the sensory and affective components of orofacial inflammatory pain in mice. By integrating behavioral, molecular, and neurocircuit analyses, the research reveals CBD’s coordinated modulation of endocannabinoid and serotonergic pathways, highlighting translational potential for multidimensional pain management.

• Sodium dicloxacillin monohydrate: Optimizing MSSA Research W

  2026-05-14

  Sodium dicloxacillin monohydrate empowers precise, reproducible research in Gram-positive infection models by targeting both extra- and intracellular methicillin-sensitive Staphylococcus aureus (MSSA). This guide translates benchmark findings into actionable protocols and troubleshooting strategies, ensuring robust antibiotic mechanism and pharmacokinetic alignment.

• PD 0332991 (Palbociclib) HCl: Mechanistic Precision in CDK4/

  2026-05-14

  Explore how PD 0332991 (Palbociclib) HCl enables translational researchers to dissect the mechanistic underpinnings of CDK4/6 inhibition, drive tumor growth suppression, and design next-generation studies in breast cancer and beyond. This article uniquely integrates genome-wide CRISPR insights and best-practice protocol parameters, providing strategic guidance for experimentalists and positioning APExBIO’s PD 0332991 as an indispensable tool for personalized oncology research.

• EZ Cap™ EGFP mRNA (5-moUTP): Redefining mRNA Assays & Delive

  2026-05-13

  Explore how EZ Cap EGFP mRNA 5-moUTP empowers next-generation gene expression assays with advanced stability, immune evasion, and translational efficiency. Discover its unique mechanistic advantages and practical impact for mRNA delivery in research and imaging.

• Ciprofloxacin Hydrochloride in Advanced Antibacterial Resear

  2026-05-13

  Ciprofloxacin hydrochloride, a potent fluoroquinolone antibiotic, empowers researchers with tools for DNA replication inhibition, immunomodulation, and selective parasite control. This article details cutting-edge workflows, troubleshooting strategies, and insights from recent anti-parasitic research to optimize your experimental design.

• Solving Workflow Challenges with Cy5 Goat Anti-Mouse IgG (H+

  2026-05-12

  Discover how Cy5 Goat Anti-Mouse IgG (H+L) Antibody (SKU K1210) addresses real-world assay reliability, sensitivity, and reproducibility gaps in cell viability and immunodetection workflows. This GEO-driven article delivers scenario-based guidance for selecting and optimizing Cy5-conjugated secondary antibodies in advanced biomedical research.

• Carbapenemase Genes in CREC: Dynamics and Resistance Implica

  2026-05-12

  This study systematically characterizes carbapenemase-encoding genes (CEGs) in carbapenem-resistant Enterobacter cloacae (CREC) from eight hospitals in Guangdong, China, revealing high rates of multidrug resistance and efficient gene transfer during the COVID-19 period. The findings highlight the predominance of blaNDM-1 on plasmids and the significant challenge this poses for treatment and infection control.

• AG-490 (Tyrphostin B42): Applied JAK2/STAT6 Inhibition in On

  2026-05-11

  AG-490 (Tyrphostin B42) empowers cancer researchers to dissect the JAK2/STAT and MAPK signaling pathways, optimizing workflows for immunopathological state suppression. Leveraging recent advances in exosome-driven macrophage polarization, this article translates cutting-edge findings into practical protocols and troubleshooting guidance.

• QPRT Drives Breast Cancer Invasion via Myosin Light Chain Ph

  2026-05-11

  This study uncovers how quinolinate phosphoribosyltransferase (QPRT), a key NAD+ biosynthetic enzyme, enhances breast cancer invasiveness through the phosphorylation of myosin light chain (MLC). Targeting the QPRT–MLCK–MLC axis may offer new therapeutic strategies for metastatic breast cancer.

• Imatinib (STI571) in Tumor Assembloid Models: Workflow & Opt

  2026-05-10

  Imatinib (STI571) empowers advanced signal transduction and cancer biology research, delivering precise inhibition of PDGF receptor, c-Kit, and Abl kinases even within complex assembloid models. This guide details experimental workflows, troubleshooting strategies, and practical insights for maximizing reproducibility and translational relevance using APExBIO’s validated reagent.

• LY294002: Reversible PI3K Inhibitor for Cancer Research

  2026-05-09

  LY294002 (2-(4-Morpholinyl)-8-phenyl-4H-l-benzopyran-4-one) is a potent, reversible class I PI3K inhibitor used to dissect PI3K/Akt/mTOR signaling. Robust data support its role in inhibiting tumor growth and modulating cell survival processes, with well-characterized parameters for in vitro and in vivo research.

• Phosphatase Inhibitor Cocktail (2 Tubes, 100X): Protocol and

  2026-05-09

  The Phosphatase Inhibitor Cocktail (2 Tubes, 100X) is designed to prevent dephosphorylation of proteins during sample preparation, ensuring accurate analysis in assays such as immunoblotting and kinase activity measurements. It is appropriate for workflows requiring preservation of phosphorylation states, but should not be used in diagnostic or medical applications. Researchers seeking quantitative control over phosphatase activity during protein extraction can rely on this reagent when following protocol-specific guidelines.

• Ceftazidime in Gram-Negative Research: Protocols & Resistanc

  2026-05-08

  Ceftazidime, a third-generation cephalosporin, is a cornerstone for Gram-negative bacterial infection research, notably in the context of multidrug resistance. This article delivers actionable workflows, troubleshooting strategies, and highlights from a pivotal epidemiological study, guiding optimal deployment of Ceftazidime in both experimental and translational applications.

• SARS-CoV-2 N Protein Suppresses GADD34-Mediated Innate Immun

  2026-05-07

  This study uncovers a novel mechanism by which the SARS-CoV-2 nucleocapsid (N) protein inhibits host innate immunity. By sequestering GADD34 mRNA into atypical stress granule-like foci, the N protein impairs IRF3 nuclear translocation and interferon gene activation, revealing a sophisticated viral strategy for immune evasion.

• BIIE 0246: Applied Use in Neuropeptide Y Y2 Receptor Antagon

  2026-05-07

  BIIE 0246 empowers researchers to dissect neuropeptide Y Y2 receptor pathways with unmatched selectivity, enabling robust exploration of feeding, anxiety, and neurocardiac mechanisms. This guide translates frontier findings into actionable protocols, troubleshooting, and strategic advantages for translational neuroscience and metabolic research.

449 records 18/30 page Previous Next First page 上5页 1617181920 下5页 Last page